Could a simple blood test finally diagnose TB in kids?

NCT ID NCT06113861

Recruiting now Diagnosis Sponsor: Tulane University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is testing a new blood test called CRISPR-TB to diagnose tuberculosis (TB) in children more accurately. Current tests often miss TB in kids because they have fewer bacteria. The study will enroll 1,220 children in Bolivia to see if this test can detect TB better than standard methods. If it works, it could make TB diagnosis easier and faster in places with limited resources.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CRISPR-TB blood test (cell-free DNA test)
What this could lead to: If successful, this could provide a simple, accurate blood test to diagnose tuberculosis in children, especially in low-resource settings where current tests often fail.
What could go wrong: This is an early-stage diagnostic study, not a treatment trial. The test's accuracy in real-world conditions may differ from pilot results, and it may not be widely available soon.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

tuberculosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TUBERCULOSIS

Contacts and locations

Locations

Hospital de Ninos "Mario Ortiz Suarez"
RECRUITING

Santa Cruz, Bolivia

More trials for these conditions

Other studies related to the condition(s) this trial covers.